LifeGuard+
Natural health product licensed in Canada
- Licence holder
- Mineral Medix Corp.
- NPN or DIN-HM
- 80086725
- Status
- Active licence
- Licence date
- 29 June 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Phosphatidylsérine Source : Phosphatidylserine | 70 milligramme | Not calculated |
| Phosphatidylcholine Source : Phosphatidylcholine | 140 milligramme | Not calculated |
| 5-Hydroxy-L-tryptophane Source : Griffonia simplicifolia, graine | 100 milligramme | Not calculated |
| Acide gamma-aminobutyrique Source : Acide glutamique | 200 milligramme | Not calculated |
| L-phénylalanine Source : DL-phénylalanine | 150 milligramme | Not calculated |
Non-medicinal ingredients
Cire d'abeille jaune, Huile de fève de soja, Stéarate de magnésium, Lécithine, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 3 days |
Uses authorised in Canada
-Helps to promote healthy mood balance -Helps to relieve symptoms of fibromyalgia -Helps to reduce the severity and duration of migraine headaches when taken as a prophylactic.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you have scleroderma. Do not use with Alcohol. Do not use if you have Phenylketonuria. Do not use if you are taking Levodopa, a medication used to treat Parkinson's disease. Do not use if you have tardive dyskinesia.
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you are taking carbidopa or drugs/supplements with serotonergic activity. These may include, but are not limited to, L-tryptophan, S-adenosylmethionine (SAMe), St. John's wort, antidepressants, pain killers, over the counter cough and cold medication containing dextromethorphan, anti-nausea medication and anti-migraine medication. Discontinue use and consult a health care practitioner if you show signs of weakness, oral ulcers, or abdominal pain accompanied by severe muscle pain or if you experience skin changes. Ensure to drink enough fluid before, during, and after exercise. Consult a health care practitioner prior to use if you are taking antidepressant drugs such as MAOIs or SSRIs or other anti-psychotic medications.
- Effets indésirables connus
Some people may experience drowsiness. Exercise caution if operating heavy machinery, driving a motor vehicle or involved in activities requiring mental alertness Some people may experience diarrhea, nausea, vomiting and abdominal pain.
Source
Official Health Canada record, licence 80086725
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.